Literature DB >> 20231129

Primary intracranial malignant peripheral nerve sheath tumour responding to chemotherapy.

Francisco Zambrana1, Francisco Vicente, Teresa García-Manrique, Sofía Pereira, Jesús Sáinz De Zaitigui, Luis De La Cruz Merino.   

Abstract

Malignant peripheral nerve sheath tumours (MPNST) are a rare variety of soft tissue sarcomas (STS) arising from major peripheral nerve branches and typically located in the lower extremity, chest wall or the retroperitoneum. It is a biologically aggressive neoplasm for which the treatment of choice is surgery, but usually requires a multimodality approach, having been generally labelled as chemoresistant. We present a case of MPNST located intracranially with a good response to chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20231129     DOI: 10.1007/s12094-010-0494-8

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  9 in total

1.  Spinal intradural tumours: Part I--Extramedullary.

Authors:  W el-Mahdy; P J Kane; M P Powell; H A Crockard
Journal:  Br J Neurosurg       Date:  1999-12       Impact factor: 1.596

2.  Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group.

Authors:  Modesto Carli; Andrea Ferrari; Adrian Mattke; Ilaria Zanetti; Michela Casanova; Gianni Bisogno; Giovanni Cecchetto; Rita Alaggio; Luigi De Sio; Ewa Koscielniak; Eura Koscielniak; Guido Sotti; Joern Treuner
Journal:  J Clin Oncol       Date:  2005-11-20       Impact factor: 44.544

3.  The relationship between melanocytes and peripheral nerve sheath cells (Part I): melanocytic nevus (excluding so-called "blue nevus") with peripheral nerve sheath differentiation.

Authors:  N Misago
Journal:  Am J Dermatopathol       Date:  2000-06       Impact factor: 1.533

4.  Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution.

Authors:  Matteo Anghileri; Rosalba Miceli; Marco Fiore; Luigi Mariani; Andrea Ferrari; Chiara Mussi; Laura Lozza; Paola Collini; Patrizia Olmi; Paolo G Casali; Silvana Pilotti; Alessandro Gronchi
Journal:  Cancer       Date:  2006-09-01       Impact factor: 6.860

Review 5.  Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis.

Authors:  J M Woodruff
Journal:  Am J Med Genet       Date:  1999-03-26

Review 6.  Malignant Peripheral Nerve Sheath Tumor: molecular pathogenesis and current management considerations.

Authors:  Stephen R Grobmyer; John D Reith; Amir Shahlaee; Charles H Bush; Steven N Hochwald
Journal:  J Surg Oncol       Date:  2008-03-15       Impact factor: 3.454

7.  Localized extremity soft tissue sarcoma: an analysis of factors affecting survival.

Authors:  C Collin; J Godbold; S Hajdu; M Brennan
Journal:  J Clin Oncol       Date:  1987-04       Impact factor: 44.544

8.  Malignant schwannoma--clinical characteristics, survival, and response to therapy.

Authors:  P P Sordillo; L Helson; S I Hajdu; G B Magill; C Kosloff; R B Golbey; E J Beattie
Journal:  Cancer       Date:  1981-05-15       Impact factor: 6.860

9.  Malignant peripheral nerve sheath tumors (MPNST)--clinicopathological study and treatment outcome of twenty-four cases.

Authors:  Madhabananda Kar; S V Suryanarayana Deo; Nootan Kumar Shukla; Ajay Malik; Sidharth DattaGupta; Bidhu Kumar Mohanti; Sanjay Thulkar
Journal:  World J Surg Oncol       Date:  2006-08-22       Impact factor: 2.754

  9 in total
  2 in total

1.  Advanced epithelioid malignant peripheral nerve sheath tumor showing complete response to combined surgery and chemotherapy: a case report.

Authors:  Tomohiro Minagawa; Ryuta Shioya; Chigusa Sato; Ryuji Shichinohe; Go Yasui; Kohsuke Ishikawa; Hiroko Takahashi
Journal:  Case Rep Oncol Med       Date:  2011-09-06

2.  Tumor targeted delivery of doxorubicin in malignant peripheral nerve sheath tumors.

Authors:  A B Madhankumar; Oliver D Mrowczynski; Becky Slagle-Webb; Vagisha Ravi; Alexandre J Bourcier; Russell Payne; Kimberly S Harbaugh; Elias Rizk; James R Connor
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.